{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T01:13:48Z","timestamp":1794273228727,"version":"4.9.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 82560609"],"award-info":[{"award-number":["No. 82560609"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Natural Science Foundation of Xinjiang Uygur Autonomous Region, \u201cTianchi\u201d talent introduction program","award":["No. 65310025P000013109145"],"award-info":[{"award-number":["No. 65310025P000013109145"]}]},{"name":"Science and Technology Program of Health Commission of Xinjiang Uygur Autonomous Region","award":["No.2025001QNKYXM653125763"],"award-info":[{"award-number":["No.2025001QNKYXM653125763"]}]},{"name":"National Key Clinical Specialty Construction Project","award":["No. 10000015Z155080000004"],"award-info":[{"award-number":["No. 10000015Z155080000004"]}]},{"name":"Shanghai Pudong New Area Science and Technology Development Fund \u201cMedical and health special subproject\u201d","award":["No. PKJ2023-Y28"],"award-info":[{"award-number":["No. PKJ2023-Y28"]}]},{"name":"Project of the National Natural Science Foundation Cultivation Fund, Gongli Hospital, Pudong New Area","award":["No. 2024GPY-A03"],"award-info":[{"award-number":["No. 2024GPY-A03"]}]},{"name":"New Quality Clinical Specialty Program of High-end Medical Disciplinary Construction in Shanghai Pudong New Area","award":["No. 2024-PWXZ-13"],"award-info":[{"award-number":["No. 2024-PWXZ-13"]}]},{"name":"Key Discipline Development Initiative of the Shanghai Health System","award":["No. 2024ZDXK0043"],"award-info":[{"award-number":["No. 2024ZDXK0043"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Digit. Med."],"DOI":"10.1038\/s41746-025-02297-4","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T23:05:34Z","timestamp":1767740734000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Integrative single-cell and spatial transcriptomics with explainable AI reveal lethal prognostic axis in prostate cancer"],"prefix":"10.1038","volume":"9","author":[{"given":"Qintao","family":"Ge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenda","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonghui","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenkai","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youzhao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingwei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mierxiati","family":"Abudurexiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,6]]},"reference":[{"key":"2297_CR1","doi-asserted-by":"publisher","unstructured":"Han, B. et al. Cancer incidence and mortality in China, 2022. J. Natl. Cancer Cent. https:\/\/doi.org\/10.1016\/j.jncc.2024.01.006 (2024).","DOI":"10.1016\/j.jncc.2024.01.006"},{"key":"2297_CR2","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229\u2013263 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"2297_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.811044","volume":"10","author":"L Wang","year":"2022","unstructured":"Wang, L. et al. Prostate cancer incidence and mortality: global status and temporal trends in 89 countries from 2000 to 2019. Front. Public Health 10, 811044 (2022).","journal-title":"Front. Public Health"},{"key":"2297_CR4","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/S0140-6736(24)00651-2","volume":"403","author":"ND James","year":"2024","unstructured":"James, N. D. et al. The lancet commission on prostate cancer: planning for the surge in cases. Lancet 403, 1683\u20131722 (2024).","journal-title":"Lancet"},{"key":"2297_CR5","doi-asserted-by":"publisher","unstructured":"Huang, F., Li, K., Shevach, J. W. & Wang, Q. Emerging therapies to overcome antiandrogen resistance and beyond in lethal prostate cancer. J. Natl. Cancer Cent. https:\/\/doi.org\/10.1016\/j.jncc.2025.04.004 (2025).","DOI":"10.1016\/j.jncc.2025.04.004"},{"key":"2297_CR6","doi-asserted-by":"publisher","unstructured":"Wang, Z. et al. Prostate cancer in China: epidemiological trends, genomic insights, and future directions for optimized management. J. Natl. Cancer Cent. https:\/\/doi.org\/10.1016\/j.jncc.2025.05.002 (2025).","DOI":"10.1016\/j.jncc.2025.05.002"},{"key":"2297_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-024-00564-3","volume":"8","author":"G Fan","year":"2024","unstructured":"Fan, G. et al. Single-cell and spatial analyses revealed the co-location of cancer stem cells and SPP1+ macrophage in hypoxic region that determines the poor prognosis in hepatocellular carcinoma. NPJ Precis. Oncol. 8, 75 (2024).","journal-title":"NPJ Precis. Oncol."},{"key":"2297_CR8","doi-asserted-by":"publisher","first-page":"5312","DOI":"10.7150\/thno.109097","volume":"15","author":"Q Ge","year":"2025","unstructured":"Ge, Q. et al. Spatially segregated APOE(+) macrophages restrict immunotherapy efficacy in clear cell renal cell carcinoma. Theranostics 15, 5312\u20135336 (2025).","journal-title":"Theranostics"},{"key":"2297_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.461","volume":"5","author":"W Xu","year":"2024","unstructured":"Xu, W. et al. Unveiling the impact of tertiary lymphoid structures on immunotherapeutic responses of clear cell renal cell carcinoma. MedComm 5, e461 (2024).","journal-title":"MedComm"},{"key":"2297_CR10","first-page":"280","volume":"4","author":"D Zhao","year":"2024","unstructured":"Zhao, D. et al. Establishing the homologous recombination score threshold in metastatic prostate cancer patients to predict the efficacy of PARP inhibitors. J. Natl. Cancer Cent. 4, 280\u2013287 (2024).","journal-title":"J. Natl. Cancer Cent."},{"key":"2297_CR11","doi-asserted-by":"publisher","unstructured":"Wang, Z. et al. Spatial and maturity heterogeneity of tertiary lymphoid structures shapes the immune microenvironment and progression in prostate cancer. J. Natl. Cancer Cent. https:\/\/doi.org\/10.1016\/j.jncc.2025.06.003 (2025).","DOI":"10.1016\/j.jncc.2025.06.003"},{"key":"2297_CR12","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1038\/s41588-025-02139-9","volume":"57","author":"J Hu","year":"2025","unstructured":"Hu, J. et al. Spatially resolved transcriptomic analysis of the adult human prostate. Nat. Genet. 57, 922\u2013933 (2025).","journal-title":"Nat. Genet."},{"key":"2297_CR13","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/s43587-025-00842-0","volume":"5","author":"Y Cheng","year":"2025","unstructured":"Cheng, Y. et al. Single-cell and spatial RNA sequencing identify divergent microenvironments and progression signatures in early- versus late-onset prostate cancer. Nat. Aging 5, 909\u2013928 (2025).","journal-title":"Nat. Aging"},{"key":"2297_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01863-2","volume":"22","author":"S Figiel","year":"2023","unstructured":"Figiel, S. et al. Spatial transcriptomic analysis of virtual prostate biopsy reveals confounding effect of tissue heterogeneity on genomic signatures. Mol. Cancer 22, 162 (2023).","journal-title":"Mol. Cancer"},{"key":"2297_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54771-4","volume":"15","author":"Z Cai","year":"2024","unstructured":"Cai, Z. et al. Synthetic augmentation of cancer cell line multi-omic datasets using unsupervised deep learning. Nat. Commun. 15, 10390 (2024).","journal-title":"Nat. Commun."},{"key":"2297_CR16","doi-asserted-by":"publisher","first-page":"13844","DOI":"10.1021\/acs.est.5c04054","volume":"59","author":"TR Lane","year":"2025","unstructured":"Lane, T. R. et al. Machine learning and large language models for modeling complex toxicity pathways and predicting steroidogenesis. Environ. Sci. Technol. 59, 13844\u201313856 (2025).","journal-title":"Environ. Sci. Technol."},{"key":"2297_CR17","doi-asserted-by":"publisher","first-page":"103470","DOI":"10.1016\/j.redox.2024.103470","volume":"79","author":"X Qi","year":"2025","unstructured":"Qi, X. et al. Machine learning and SHAP value interpretation for predicting comorbidity of cardiovascular disease and cancer with dietary antioxidants. Redox Biol. 79, 103470 (2025).","journal-title":"Redox Biol."},{"key":"2297_CR18","doi-asserted-by":"publisher","first-page":"9551","DOI":"10.2147\/JIR.S488676","volume":"17","author":"Z Zhu","year":"2024","unstructured":"Zhu, Z. et al. Integrating machine learning and the SHapley Additive exPlanations (SHAP) framework to predict lymph node metastasis in gastric cancer patients based on inflammation indices and peripheral lymphocyte subpopulations. J. Inflamm. Res. 17, 9551\u20139566 (2024).","journal-title":"J. Inflamm. Res."},{"key":"2297_CR19","doi-asserted-by":"publisher","first-page":"8737","DOI":"10.1007\/s00330-022-08887-0","volume":"32","author":"Y Wang","year":"2022","unstructured":"Wang, Y. et al. The radiomic-clinical model using the SHAP method for assessing the treatment response of whole-brain radiotherapy: a multicentric study. Eur. Radiol. 32, 8737\u20138747 (2022).","journal-title":"Eur. Radiol."},{"key":"2297_CR20","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s10495-024-02050-4","volume":"30","author":"AH Hounye","year":"2025","unstructured":"Hounye, A. H., Xiong, L. & Hou, M. Integrated explainable machine learning and multi-omics analysis for survival prediction in cancer with immunotherapy response. Apoptosis 30, 364\u2013388 (2025).","journal-title":"Apoptosis"},{"key":"2297_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28421-6","volume":"13","author":"Z Liu","year":"2022","unstructured":"Liu, Z. et al. Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer. Nat. Commun. 13, 816 (2022).","journal-title":"Nat. Commun."},{"key":"2297_CR22","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nrurol.2018.9","volume":"15","author":"T Jamaspishvili","year":"2018","unstructured":"Jamaspishvili, T. et al. Clinical implications of PTEN loss in prostate cancer. Nat. Rev. Urol. 15, 222\u2013234 (2018).","journal-title":"Nat. Rev. Urol."},{"key":"2297_CR23","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.eururo.2014.10.027","volume":"67","author":"R Ferraldeschi","year":"2015","unstructured":"Ferraldeschi, R. et al. PTEN protein loss and clinical outcome from castration-resistant prostate cancer treated with abiraterone acetate. Eur. Urol. 67, 795\u2013802 (2015).","journal-title":"Eur. Urol."},{"key":"2297_CR24","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1038\/s41416-020-0834-6","volume":"122","author":"T Vidotto","year":"2020","unstructured":"Vidotto, T. et al. Emerging role of PTEN loss in evasion of the immune response to tumours. Br. J. Cancer 122, 1732\u20131743 (2020).","journal-title":"Br. J. Cancer"},{"key":"2297_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13039-017-0348-y","volume":"11","author":"T Vidotto","year":"2018","unstructured":"Vidotto, T., Tiezzi, D. G. & Squire, J. A. Distinct subtypes of genomic PTEN deletion size influence the landscape of aneuploidy and outcome in prostate cancer. Mol. Cytogenet. 11, 1 (2018).","journal-title":"Mol. Cytogenet."},{"key":"2297_CR26","doi-asserted-by":"publisher","unstructured":"Li, X., Han, Z. & Ai, J. Synergistic targeting strategies for prostate cancer. Nat. Rev. Urol. https:\/\/doi.org\/10.1038\/s41585-025-01042-6 (2025).","DOI":"10.1038\/s41585-025-01042-6"},{"key":"2297_CR27","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/s41586-023-06696-z","volume":"623","author":"C Guo","year":"2023","unstructured":"Guo, C. et al. Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance. Nature 623, 1053\u20131061 (2023).","journal-title":"Nature"},{"key":"2297_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2024.101158","volume":"77","author":"D Gao","year":"2024","unstructured":"Gao, D. et al. Acetate utilization promotes hormone therapy resistance in prostate cancer through neuroendocrine differentiation. Drug Resist. Updat. 77, 101158 (2024).","journal-title":"Drug Resist. Updat."},{"key":"2297_CR29","first-page":"21","volume":"11","author":"DC Feng","year":"2024","unstructured":"Feng, D. C. et al. The implications of single-cell RNA-seq analysis in prostate cancer: unraveling tumor heterogeneity, therapeutic implications and pathways towards personalized therapy. Mil. Med. Res. 11, 21 (2024).","journal-title":"Mil. Med. Res."},{"key":"2297_CR30","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1038\/s41588-024-01826-3","volume":"56","author":"SG Zhao","year":"2024","unstructured":"Zhao, S. G. et al. Integrated analyses highlight interactions between the three-dimensional genome and DNA, RNA and epigenomic alterations in metastatic prostate cancer. Nat. Genet. 56, 1689\u20131700 (2024).","journal-title":"Nat. Genet."},{"key":"2297_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53233-1","volume":"15","author":"K Zhang","year":"2024","unstructured":"Zhang, K. et al. Iron-loaded cancer-associated fibroblasts induce immunosuppression in prostate cancer. Nat. Commun. 15, 9050 (2024).","journal-title":"Nat. Commun."},{"key":"2297_CR32","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","volume":"86","author":"P Cornford","year":"2024","unstructured":"Cornford, P. et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer-2024 update. Part I: screening, diagnosis, and local treatment with curative intent. Eur. Urol. 86, 148\u2013163 (2024).","journal-title":"Eur. Urol."},{"key":"2297_CR33","doi-asserted-by":"publisher","unstructured":"Zhang, Y. et al. Immunophenotype-guided interpretable radiomics model for predicting neoadjuvant anti-PD-1 response in stage III-IV d-MMR\/MSI-H colorectal cancer. J. Immunother. Cancer https:\/\/doi.org\/10.1136\/jitc-2025-011569 (2025).","DOI":"10.1136\/jitc-2025-011569"},{"key":"2297_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/hem3.70132","volume":"9","author":"JN Eckardt","year":"2025","unstructured":"Eckardt, J. N. et al. Age-stratified machine learning identifies divergent prognostic significance of molecular alterations in AML. Hemasphere 9, e70132 (2025).","journal-title":"Hemasphere"},{"key":"2297_CR35","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1056\/NEJMoa2107322","volume":"385","author":"O Sartor","year":"2021","unstructured":"Sartor, O. et al. Lutetium-177-PSMA-617 for metastatic castration-resistant prostate cancer. N. Engl. J. Med. 385, 1091\u20131103 (2021).","journal-title":"N. Engl. J. Med."},{"key":"2297_CR36","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1056\/NEJMoa2022485","volume":"383","author":"M Hussain","year":"2020","unstructured":"Hussain, M. et al. Survival with olaparib in metastatic castration-resistant prostate cancer. N. Engl. J. Med. 383, 2345\u20132357 (2020).","journal-title":"N. Engl. J. Med."},{"key":"2297_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1001297","volume":"13","author":"W Wu","year":"2022","unstructured":"Wu, W. et al. Immune microenvironment infiltration landscape and immune-related subtypes in prostate cancer. Front. Immunol. 13, 1001297 (2022).","journal-title":"Front. Immunol."},{"key":"2297_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-023-02266-7","volume":"22","author":"W Xu","year":"2024","unstructured":"Xu, W. et al. Single-cell RNA-seq analysis decodes the kidney microenvironment induced by polystyrene microplastics in mice receiving a high-fat diet. J. Nanobiotechnology 22, 13 (2024).","journal-title":"J. Nanobiotechnology"},{"key":"2297_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54364-1","volume":"15","author":"A Kiviaho","year":"2024","unstructured":"Kiviaho, A. et al. Single cell and spatial transcriptomics highlight the interaction of club-like cells with immunosuppressive myeloid cells in prostate cancer. Nat. Commun. 15, 9949 (2024).","journal-title":"Nat. Commun."},{"key":"2297_CR40","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1016\/j.ccell.2023.10.006","volume":"41","author":"JE Hawley","year":"2023","unstructured":"Hawley, J. E. et al. Anti-PD-1 immunotherapy with androgen deprivation therapy induces robust immune infiltration in metastatic castration-sensitive prostate cancer. Cancer Cell 41, 1972\u20131988 e1975 (2023).","journal-title":"Cancer Cell"},{"key":"2297_CR41","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41556-020-00613-6","volume":"23","author":"S Chen","year":"2021","unstructured":"Chen, S. et al. Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression. Nat. Cell Biol. 23, 87\u201398 (2021).","journal-title":"Nat. Cell Biol."},{"key":"2297_CR42","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/s41586-024-08290-3","volume":"637","author":"A Lyu","year":"2025","unstructured":"Lyu, A. et al. Evolution of myeloid-mediated immunotherapy resistance in prostate cancer. Nature 637, 1207\u20131217 (2025).","journal-title":"Nature"},{"key":"2297_CR43","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ccr.2010.05.026","volume":"18","author":"BS Taylor","year":"2010","unstructured":"Taylor, B. S. et al. Integrative genomic profiling of human prostate cancer. Cancer Cell 18, 11\u201322 (2010).","journal-title":"Cancer Cell"},{"key":"2297_CR44","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587 e3529 (2021).","journal-title":"Cell"},{"key":"2297_CR45","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1038\/s41592-024-02235-4","volume":"21","author":"W Hou","year":"2024","unstructured":"Hou, W. & Ji, Z. Assessing GPT-4 for cell type annotation in single-cell RNA-seq analysis. Nat. Methods 21, 1462\u20131465 (2024).","journal-title":"Nat. Methods"},{"key":"2297_CR46","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41586-018-0694-x","volume":"564","author":"L Zhang","year":"2018","unstructured":"Zhang, L. et al. Lineage tracking reveals dynamic relationships of T cells in colorectal cancer. Nature 564, 268\u2013272 (2018).","journal-title":"Nature"},{"key":"2297_CR47","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41587-021-00830-w","volume":"40","author":"DM Cable","year":"2022","unstructured":"Cable, D. M. et al. Robust decomposition of cell type mixtures in spatial transcriptomics. Nat. Biotechnol. 40, 517\u2013526 (2022).","journal-title":"Nat. Biotechnol."},{"key":"2297_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04334-1","volume":"9","author":"QH Nguyen","year":"2018","unstructured":"Nguyen, Q. H. et al. Profiling human breast epithelial cells using single cell RNA sequencing identifies cell diversity. Nat. Commun. 9, 2028 (2018).","journal-title":"Nat. Commun."},{"key":"2297_CR49","doi-asserted-by":"publisher","first-page":"100498","DOI":"10.1016\/j.crmeth.2023.100498","volume":"3","author":"S Morabito","year":"2023","unstructured":"Morabito, S., Reese, F., Rahimzadeh, N., Miyoshi, E. & Swarup, V. hdWGCNA identifies co-expression networks in high-dimensional transcriptomics data. Cell Rep. Methods 3, 100498 (2023).","journal-title":"Cell Rep. Methods"},{"key":"2297_CR50","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.cell.2017.10.044","volume":"171","author":"SV Puram","year":"2017","unstructured":"Puram, S. V. et al. Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer. Cell 171, 1611\u20131624.e1624 (2017).","journal-title":"Cell"},{"key":"2297_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.687975","volume":"12","author":"D Zeng","year":"2021","unstructured":"Zeng, D. et al. IOBR: multi-omics immuno-oncology biological research to decode tumor microenvironment and signatures. Front. Immunol. 12, 687975 (2021).","journal-title":"Front. Immunol."}],"container-title":["npj Digital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-02297-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-02297-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-02297-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T12:04:24Z","timestamp":1770120264000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-02297-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,6]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2297"],"URL":"https:\/\/doi.org\/10.1038\/s41746-025-02297-4","relation":{},"ISSN":["2398-6352"],"issn-type":[{"value":"2398-6352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,6]]},"assertion":[{"value":"11 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"119"}}